Bain Capital Specialty Finance (BCSF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for May 22, 2025, and will be held virtually, allowing shareholders to vote and submit questions online.
Shareholders will vote on electing two Class III Directors, renewing authorization to sell shares below NAV, and potentially adjourning the meeting to solicit more proxies.
The Board unanimously recommends voting in favor of all proposals on the agenda.
Voting matters and shareholder proposals
Proposals include electing two Class III Directors for three-year terms, renewing authorization to sell shares below NAV for up to 25% of outstanding shares, and approving adjournment if needed.
The Board, including all independent directors, recommends voting “FOR” all proposals.
Shareholders have no cumulative voting rights or dissenters’ rights for these proposals.
Detailed voting instructions are provided for both record holders and those with shares in street name.
Advance notice and eligibility requirements for shareholder proposals and director nominations are outlined in the bylaws.
Board of directors and corporate governance
The Board consists of eight members, five of whom are independent under NYSE and 1940 Act standards.
Board committees include Audit, Nominating and Corporate Governance, and Compensation, all composed solely of independent directors.
The Board meets regularly, with all directors attending at least 75% of meetings in 2024.
The Nominating and Corporate Governance Committee considers diversity and a range of backgrounds in director selection.
The Chairman is an interested director, but governance practices include regular executive sessions of independent directors.
Latest events from Bain Capital Specialty Finance
- Q4 2025 saw robust NII, stable credit metrics, special dividends, and a $350M note issuance.BCSF
Q4 202527 Feb 2026 - Q2 NII was $33.1M ($0.51/share), NAV stable at $17.70, and portfolio yield reached 13.1%.BCSF
Q2 20242 Feb 2026 - Q3 2024 saw strong NII, rising NAV, and stable dividends with robust portfolio performance.BCSF
Q3 202416 Jan 2026 - Virtual meeting to elect directors, renew below-NAV share issuance, and strengthen governance.BCSF
Proxy Filing2 Dec 2025 - Strong Q4 NII, record dividends, and robust liquidity with stable credit quality.BCSF
Q4 20241 Dec 2025 - Net investment income covered dividends, with a $0.45 payout and strong portfolio diversification.BCSF
Q2 202523 Nov 2025 - Q1 net investment income per share was $0.50, with stable NAV and strong dividend coverage.BCSF
Q1 202521 Nov 2025 - Q3 2025 showed strong net investment income, robust dividend coverage, and a stable, diversified portfolio.BCSF
Q3 202517 Nov 2025